Mamegel, Magno .

HRN: 23-93-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
CEFTRIAXONE 1G (VIAL)
09/23/2024
09/29/2024
IV
1g
Q12
Pneumonia
Waiting Final Action 
09/23/2024
CEFTAZIDIME 1GM (VIAL)
09/23/2024
09/23/2024
IV
1gm
LD
Cap CKD PTB
Waiting Final Action 
09/23/2024
CEFTAZIDIME 1GM (VIAL)
09/23/2024
10/07/2024
IV
0.5gm
Q48
Cap CKD PTB
Waiting Final Action 
09/23/2024
AZITHROMYCIN 500MG TABLET (TAB)
09/23/2024
09/29/2024
PO
50mg
OD
CAP PTB CKD
Waiting Final Action 
09/24/2024
CEFTAZIDIME 1GM (VIAL)
09/24/2024
09/30/2024
IV
2gm
OD
Cap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: